ARCHIVES

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

Obituary: Carl Baker, Former NCI Director

March 13, 2009

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006